EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study

Lorenza Magagnoli, Mario Cozzolino, Fergus J Caskey, Claudia Torino, Friedo W Dekker, Marie Evans, Maciej Szymczak, Christoph Wanner, Maria Pippias, Christiane Drechsler, Antonio Vilasi, Esmee Driehuis und 5 weitere

Kidney International · 2025

DOI: 10.1016/j.kint.2025.07.032 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Kidney International, 2025. Verfasst von Lorenza Magagnoli und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Milan, Milan, Italy; ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, …. Hauptthemen laut MEDLINE: Hyperphosphatemia, Renal Insufficiency, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder, Hyperparathyroidism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nierstichting, European Renal Association European Dialysis and Transplant Association, Center for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) may be both a cause and a consequence of CKD progression. Here, we examine the individual and joint effect of longitudinal circulating phosphate, parathyroid hormone, and calcium levels on estimated glomerular filtration rate (eGFR) decline, the risk of starting dialysis and the composite risk of death or dialysis, in a cohort of elderly patients with advanced CKD not on dialysis. Secondly, we explore whether these effects differ between men and women. METHODS: We used data from 1709 participants in the European Quality study, which includes patients aged 65 and older with eGFR 20 ml/min per 1.73 m2 or less from six European countries. To avoid bias due to informative censoring, competing risks and time-varying confounding, we used the g-formula for causal inference. RESULTS: Isolated hyperphosphatemia and hyperparathyroidism were associated with a higher risk of CKD progression, whereas isolated hypercalcemia was not. The combination of hyperphosphatemia with hyperparathyroidism, and of hypocalcemia with hyperparathyroidism were also associated with significantly higher risk. The most adverse phenotype was the combination of hyperphosphatemia, hypocalcemia and hyperparathyroidism, which led to a mean difference in eGFR after three years of -3.71 ml/min (95% confidence intervals: -5.44, -2.15) and a 75% higher risk of starting dialysis (hazard ratio 1.75, 95% confidence interval 1.35-2.10), compared to having all biomarkers in their reference ranges. Most of this risk was attributable to hyperphosphatemia. Although the effect of abnormal mineral biomarkers on eGFR decline was similar between sexes, the associated risk of starting dialysis seemed stronger in men than in women. CONCLUSIONS: Among older men and women with advanced CKD not receiving dialysis, the presence of hyperphosphatemia, especially when combined with hypocalcemia and hyperparathyroidism, leads to an increased risk of CKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperphosphatemiaRenal Insufficiency, ChronicChronic Kidney Disease-Mineral and Bone DisorderHyperparathyroidismHumansFemaleMaleDisease ProgressionAgedBiomarkersGlomerular Filtration RateParathyroid HormonePhosphatesCalciumEuropeRenal DialysisHypocalcemiaSex FactorsAged, 80 and overRisk FactorsRisk Assessment

Stichwörter der Autor:innen

CKD progressionCKD-MBDPTHcalciumdialysisphosphate

Substanzen

BiomarkersParathyroid HormonePhosphatesCalcium

Autor:innen und Institutionen

  • Department of Health Sciences, University of Milan, Milan, Italy; ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, The Netherlands. Electronic address: lorenza.magagnoli@unim…
  • Department of Health Sciences, University of Milan, Milan, Italy; Renal Division, Azienda Socio-Sanitaria Territoriale (ASST) Santi Paolo e Carlo, Milan, Italy.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol United Kingdom.
  • Consiglio Nazionale Delle Ricerche - Istituto di Fisiologia Clinica (IFC-CNR), Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Renal Unit, Department of Clinical Science, Intervention and technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Förderung

  • Nierstichting
  • European Renal Association European Dialysis and Transplant Association
  • Center for Innovative Medicine
  • Sveriges Läkarförbund
  • National Institute for Health and Care Research
  • Stockholms Läns Landsting

Zitieren

APA

Magagnoli, L., Cozzolino, M., Caskey, F. J., Torino, C., Dekker, F. W., Evans, M., Szymczak, M., Wanner, C., Pippias, M., Drechsler, C., Vilasi, A., Driehuis, E., Stenvinkel, P., Stel, V. S., Jager, K. J., Chesnaye, N. C., & EQUAL Study Investigators (2025). Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study. Kidney International. https://doi.org/10.1016/j.kint.2025.07.032

Vancouver

Magagnoli L, Cozzolino M, Caskey FJ, Torino C, Dekker FW, Evans M, et al. Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study. Kidney International. 2025. doi:10.1016/j.kint.2025.07.032

BibTeX
@article{Magagnoli2025,
  author = {Magagnoli, Lorenza and Cozzolino, Mario and Caskey, Fergus J and Torino, Claudia and Dekker, Friedo W and Evans, Marie and Szymczak, Maciej and Wanner, Christoph and Pippias, Maria and Drechsler, Christiane and Vilasi, Antonio and Driehuis, Esmee and Stenvinkel, Peter and Stel, Vianda S and Jager, Kitty J and Chesnaye, Nicholas C and EQUAL Study Investigators, EQUAL Study Investigators},
  title = {Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study},
  journal = {Kidney International},
  year = {2025},
  doi = {10.1016/j.kint.2025.07.032}
}
Kostenlos starten →